1. Aoun M, Meunier F, Van der Auwera P, Delhaye N, Klastersky J. Single daily empiric antimicrobial therapy in febrile neutro-penic patients using ceftriaxone + amikacin: a pilot study. Program and Abstracts of the 28th Interscience Conference on Antimicrobial Agents and Chemotherapy, abstract 20, p. 114, Los Angeles, October 24–26, 1988
2. Briceland LL, Pasko MT, Mylotte JM. Serum bactericidal rate as measure of antibiotic interactions. Antimicrobial Agents and Chemotherapy 31: 679–685, 1987
3. De Jongh CA, Joshi JA, Thompson BW, Newman KA, Finley RS, et al, A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients. American Journal of Medicine 80(Suppl. 5C): 101–111, 1986
4. Drake TA, Hackbarth CJ, Sande MA. Value of serum tests in combined therapy of endocarditis. Antimicrobial Agents and Chemotherapy 24: 653–657, 1983
5. Jacoby GA, Stutton L. Pseudomonas cepacia susceptibility to sulbactam. Antimicrobial Agents and Chemotherapy 33: 583–584, 1989